Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakaria, Zaitun, Sapiai, Nur Asma, Ghani, Abdul Rahman Izaini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Case Report - Vascular Neurosurgery - Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186353/
https://www.ncbi.nlm.nih.gov/pubmed/34101024
http://dx.doi.org/10.1007/s00701-021-04860-w
_version_ 1783704938406215680
author Zakaria, Zaitun
Sapiai, Nur Asma
Ghani, Abdul Rahman Izaini
author_facet Zakaria, Zaitun
Sapiai, Nur Asma
Ghani, Abdul Rahman Izaini
author_sort Zakaria, Zaitun
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine.
format Online
Article
Text
id pubmed-8186353
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-81863532021-06-09 Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine Zakaria, Zaitun Sapiai, Nur Asma Ghani, Abdul Rahman Izaini Acta Neurochir (Wien) Case Report - Vascular Neurosurgery - Other The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine. Springer Vienna 2021-06-08 2021 /pmc/articles/PMC8186353/ /pubmed/34101024 http://dx.doi.org/10.1007/s00701-021-04860-w Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report - Vascular Neurosurgery - Other
Zakaria, Zaitun
Sapiai, Nur Asma
Ghani, Abdul Rahman Izaini
Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
title Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
title_full Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
title_fullStr Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
title_full_unstemmed Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
title_short Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
title_sort cerebral venous sinus thrombosis 2 weeks after the first dose of mrna sars-cov-2 vaccine
topic Case Report - Vascular Neurosurgery - Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186353/
https://www.ncbi.nlm.nih.gov/pubmed/34101024
http://dx.doi.org/10.1007/s00701-021-04860-w
work_keys_str_mv AT zakariazaitun cerebralvenoussinusthrombosis2weeksafterthefirstdoseofmrnasarscov2vaccine
AT sapiainurasma cerebralvenoussinusthrombosis2weeksafterthefirstdoseofmrnasarscov2vaccine
AT ghaniabdulrahmanizaini cerebralvenoussinusthrombosis2weeksafterthefirstdoseofmrnasarscov2vaccine

Ejemplares similares